The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
摘要:
Optimization of a series of constrained melanin-concentrating hormone receptor 1 (MCH RI) antagonists has provided compounds with potent and selective MCH R1 activity. Details of the optimization process are provided and the use of one of the compounds in an animal model of diet-induced obesity is presented. (c) 2006 Elsevier Ltd. All rights reserved.
Pyrimidinones as melanin concentrating hormone receptor 1
申请人:——
公开号:US20040220404A1
公开(公告)日:2004-11-04
A compound of formula (Ia) comprising a pharmaceutically acceptable salt or solvate thereof, formulations, processes of preparing, and methods of administering to mammals are provided
1
提供了一种化合物(Ia)的配方,包括其药用可接受的盐或溶剂,制备过程以及对哺乳动物的给药方法。
NOVEL AMINO ALCOHOL-SUBSTITUTED ARYLTHIENOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
申请人:SCHWINK Lothar
公开号:US20090076002A1
公开(公告)日:2009-03-19
The invention relates to amino alcohol-substituted arylthienopyrimidinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one amino alcohol-substituted arylthienopyrimidinone of the invention or its derivative, and the use of the amino alcohol-substituted arylthienopyrimidinones of the invention and their derivatives as MCH antagonists.
Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
申请人:Schwink Lothar
公开号:US08853208B2
公开(公告)日:2014-10-07
The invention relates to amino alcohol-substituted arylthienopyrimidinones having a formula I
and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one amino alcohol-substituted arylthienopyrimidinone of the invention or its derivative, and the use of the amino alcohol-substituted arylthienopyrimidinones of the invention and their derivatives as MCH antagonists.